BioSpace News Archive

Press Releases

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

October 9, 2024
·
6 min read
Press Releases

HotSpot Therapeutics to Present Preclinical Data from MALT1 CBM Signalosome Glue Program at 36th EORTC-NCI-AACR Symposium

October 9, 2024
·
1 min read
Press Releases

clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors

October 9, 2024
·
3 min read
Press Releases

Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy

October 9, 2024
·
9 min read
Press Releases

InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges

October 9, 2024
·
3 min read
Press Releases

Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics

October 9, 2024
·
3 min read
Press Releases

Vanqua Bio Announces Positive Interim Results from Phase 1 Clinical Trial of VQ-101, an Orally Administered, Brain-Penetrant, Allosteric Activator of GCase for the Treatment of GBA-Parkinson’s and Related Disorders

October 9, 2024
·
4 min read
Press Releases

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

October 9, 2024
·
6 min read
Press Releases

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium

October 9, 2024
·
6 min read
Press Releases

Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases

October 9, 2024
·
8 min read